Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-05

Clinical Trial Update: Pharmacokinetics Study of Cefazolin in Hemodialysis (CEFAZODIAL) [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetics study of cefazolin in patients undergoing hemodialysis (CEFAZODIAL) is currently active/not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CEFAZOLIN (cefazolin sodium)

Snippet

Sponsor: University Hospital, Tours | Conditions: Hemodialysis Catheter Infection, Infection, Bacterial | Phase 4 | Status: ACTIVE_NOT_RECRUITING